Start for free
Start for free
S

Spinventure

Europe, Liege, Belgium, Angleur

Description

Spinventure supports the creation of spin-off companies that aim to industrialize and commercialize the result of scientific research.

Investor Profile

Spinventure has made 6 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (83%)
  • Series Unknown (17%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Medical Device
  • Therapeutics
  • Business Development
  • Pharmaceutical
  • Clinical Trials
  • Innovation Management
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Spinventure frequently co-invest with?

E
Eurostars
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
AI
Agri Investment Fund
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
Droia Ventures
Droia Ventures
Europe, Luxembourg, Luxembourg, Luxembourg
Co-Investments: 1
Meusinvest (Noshaq)
Meusinvest (Noshaq)
Europe, Liege, Belgium, Liège
Co-Investments: 2
GoBeyond
GoBeyond
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
NI
Notger invest
Europe, Liege, Belgium, Angleur
Co-Investments: 1
Spreds
Spreds
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
KBC
KBC
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
Inventures SA
Inventures SA
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
W
Walloon
Europe, Namur, Belgium, Namur
Co-Investments: 1

Which angels does Spinventure often collaborate with?

JD
Jean-Pierre Delwart
Europe, Namur, Belgium, Havelange
Shared Deals: 1
EJ
Shared Deals: 1

What are some of recent deals done by Spinventure?

Convert Pharmaceuticals

Liège, Liege, Belgium

Convert Pharmaceuticals is a research and development company.

BiotechnologyBusiness DevelopmentPharmaceutical
Series AFeb 28, 2018
Amount Raised: $16,580,796
Cell Matters

Liège, Liege, Belgium

Cell Matters specializes in cell therapy productivity, turning cryopreservation into a competitive advantage.

BiotechnologyInnovation ManagementTherapeutics
Series AJan 23, 2018
Amount Raised: $876,393
Dim3

Beaufays, Liege, Belgium

DIM3 develops and markets innovative clinical expert platforms and medical devices.

Health CareMedicalMedical Device
Series UnknownSep 26, 2017
Amount Raised: $4,713,463
Elysia

Liège, Liege, Belgium

Elysia developed solution dedicated to quality control laboratories for the production of Radio Pharmaceuticals.

Health CareMedical
Series AJun 30, 2015
Amount Raised: $1,348,981
2-Observe

Ferrières, Liege, Belgium

2-Observe developed a concept of patient monitoring designed specifically for hospitals' general services and nursing homes.

BiotechnologyHealth CareMedical Device
Series AJun 17, 2015
Amount Raised: $793,504
Okapi Sciences

Heverlee, Vlaams-Brabant, Belgium

Okapi Sciences NV, a Belgium-based company with a proprietary pet therapeutics antiviral platform and five clinical/development stage

BiotechnologyClinical TrialsTherapeutics
Series ANov 3, 2008
Amount Raised: $10,785,912
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator